Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 0.662M
March 31, 2026 -0.336M
December 31, 2025 1.063M
September 30, 2025 -0.53M
June 30, 2025 2.065M
March 31, 2025 -0.735M
December 31, 2024 2.976M
September 30, 2024 0.798M
June 30, 2024 111.55M
March 31, 2024 7.992M
December 31, 2023 5.15M
September 30, 2023 -8.189M
June 30, 2023 1.263M
Date Value
March 31, 2023 65.54M
December 31, 2022 6.308M
September 30, 2022 -0.453M
June 30, 2022 0.72M
March 31, 2022 -0.098M
December 31, 2021 0.404M
September 30, 2021 120.55M
June 30, 2021 10.25M
March 31, 2021 6.144M
December 31, 2020
September 30, 2020
June 30, 2020 0.782M
March 31, 2020 0.075M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Precision Optics Corp., Inc. 10.47M
Alcon AG -510.00M
The Cooper Cos., Inc. -75.80M
UFP Technologies, Inc. -25.36M
TransMedics Group, Inc. 0.97M